The immunotherapy protocol successfully treated 100% of rectal cancer patients involved in the trial, according to reports. Getty Images In all 49 rectal cancer patients, there was no evidence of ...

Rectal cancer is relatively common, with about 46,220 new cases diagnosed in the United States each year (27,330 in men and 18,890 in women), according to the American Cancer Society.

MRI can save rectal cancer patients from surgery, study suggests Date: October 22, 2024 Source: University of Virginia Health System Summary: MRI can predict the risk of rectal cancer reccurring ...

Rectal cancer is typically treated at first with radiation and chemotherapy, but some patients require what is known as "total mesorectal excision" – the removal of a substantial portion of ...

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, offering patients an alternative to chemotherapy and surgery.

The National Comprehensive Cancer Network mirrored the definition when, for the first time, it recommended watch-and-wait as an option for near-complete response in its 2023 rectal cancer guidelines.

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery and other types of more invasive treatment to cure their disease.

New Research Shows It’s Safe to Watch and Wait Before Surgery To Remove Rectum Rectal cancer research at MSK and elsewhere shows that watch and wait for localized rectal cancer appears to be just as ...

Now, “what we just published shows two things. Those rectal cancer patients remain at 100%, at almost 50 patients responding completely, but it’s durable.

Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering ...

City of Hope's DINOMITE trial has a primary goal of determining the side effect profile and most effective dose of papaverine when given with radiation therapy to patients with rectal cancer that ...